title: CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
authors.affiliation: Department of Dermatology, University of Occupational and Environmental Health. 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.
authors.forename: Akiha
authors.initials: A
authors.lastname: Inoue
authors.forename: Yu
authors.initials: Y
authors.lastname: Sawada
authors.forename: Shun
authors.initials: S
authors.lastname: Ohmori
authors.forename: Daisuke
authors.initials: D
authors.lastname: Omoto
authors.forename: Sanehito
authors.initials: S
authors.lastname: Haruyama
authors.forename: Manabu
authors.initials: M
authors.lastname: Yoshioka
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nishio
authors.forename: Motonobu
authors.initials: M
authors.lastname: Nakamura
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D015415:Biomarkers / Q000032:analysis; D001706:Biopsy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D017730:Ki-1 Antigen / Q000032:analysis*; D019310:Pseudolymphoma / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D012074:Remission Induction; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015415:Biomarkers; D005938:Glucocorticoids; D017730:Ki-1 Antigen; C502936:tocilizumab